IP Verse

Kymera Therapeutics, Inc. v. Dana-Farber Cancer Institute, Inc. - PGR2021-00115

Explore the PTAB proceeding PGR2021-00115 filed by Kymera Therapeutics, Inc. against Dana-Farber Cancer Institute, Inc. on Aug 24, 2021. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
PGR2021-00115
Filing Date
Aug 24, 2021
Petitioner
Kymera Therapeutics, Inc.
Respondent
Dana-Farber Cancer Institute, Inc.
Status
Institution Denied
Respondent Application Number
16264266
Respondent Tech Center
1600
Respondent Patent Number
10849980
Institution Decision Date
Mar 2, 2022
Termination Date
Mar 2, 2022

Decision Documents New

Decision pending - set alert to receive updates

Counsels Involved New

Details of counsels involved in proceeding number PGR2021-00115.

TypeName
Petitioner CounselAmanda Antons
Respondent CounselChristopher Schultz

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.